Martin Mackay - May 15, 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Martin Mackay
Stock symbol
CRL
Transactions as of
May 15, 2023
Transactions value $
$321,049
Form type
4
Date filed
5/17/2023, 02:43 PM
Previous filing
Feb 6, 2023
Next filing
Jun 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +664 +6.32% $0.00 11.2K May 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $321K +1.67K $192.36 1.67K May 15, 2023 Common Stock 1.67K $192.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.
F2 The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders.